Empagliflozin prevents heart failure through inhibition of the NHE1-NO pathway, independent of SGLT2
恩格列净通过抑制 NHE1-NO 通路来预防心力衰竭，而不依赖于 SGLT2
期刊:Basic Research in Cardiology
影响因子:7.5
doi:10.1007/s00395-024-01067-9
Sha Chen, Qian Wang, Diane Bakker, Xin Hu, Liping Zhang, Ingeborg van der Made, Anna M Tebbens, Csenger Kovácsházi, Zoltán Giricz, Gábor B Brenner, Peter Ferdinandy, Gert Schaart, Anne Gemmink, Matthijs K C Hesselink, Mathilde R Rivaud, Michael P Pieper, Markus W Hollmann, Nina C Weber, Jean-Luc Bal
